Background . Septic shock is common and results in significant morbidity and mortality.
Adjunctive treatment with corticosteroids is common, but definitive data are lacking. We aimed to …

Objective: Some studies suggest better outcomes with macrolide therapy for critically ill patients
with community-acquired pneumonia. To further explore this, we performed a systematic …

Background. Macrolides are used to treat pneumonia despite increasing antimicrobial resistance.
However, the immunomodulatory properties of macrolides may have a favorable effect …

Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …

Background Community-acquired pneumonia (CAP) is a common and serious condition.
Combined with influenza, pneumonia is the most frequent cause of infection-related death …

Objectives To describe the epidemiology, antimicrobial susceptibilities, treatment, and outcomes
of intensive care unit (ICU)-acquired Gram-negative bacteremia. Methods Patients with …

Background Pulmonary aspergillosis may complicate coronavirus disease 2019 (COVID-19)
and contribute to excess mortality in intensive care unit (ICU) patients. The disease is …

BACKGROUND The interleukin-6 receptor antagonist tocilizumab improves outcomes in
critically ill patients with coronavirus disease 2019 (COVID-19). However, the effectiveness of …

Objective: To determine the association between age and mortality in critically ill patients with
pneumonia. We hypothesized that increasing age would be independently associated with …

… Correspondence to Wendy Sligl, University of Alberta Hospital, 2-124 Clinical Sciences
Building, 8440 112 St., NW Edmonton, Alberta T6B 2G7, Canada. Tel: +1 780 492 8597; fax …